TINA PAI

Allopathic & Osteopathic Physicians|Dermatology TUCSON, AZ NPI 1972630366

General Payments — all program years on this page

$2,716.26

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 146
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $873.32 across 42 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $873.3242

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $502.1430
REVANCE THERAPEUTICS, INC. $310.658
Galderma Laboratories, L.P. $60.534

By program year

Program yearAmountRecords
2018 $244.6217
2019 $568.0530
2020 $56.253
2021 $316.3514
2022 $337.6715
2023 $320.0025
2024 $873.3242

Records — PY2024 (42)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1105169877 ABBVIE INC. $13.45 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169879 ABBVIE INC. $18.99 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169881 ABBVIE INC. $15.89 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169883 ABBVIE INC. $30.03 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169885 ABBVIE INC. $14.56 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169887 ABBVIE INC. $18.92 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169889 ABBVIE INC. $25.34 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169891 ABBVIE INC. $12.77 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169893 ABBVIE INC. $16.75 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169895 ABBVIE INC. $15.71 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169897 ABBVIE INC. $18.15 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169899 ABBVIE INC. $25.50 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169901 ABBVIE INC. $17.22 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169903 ABBVIE INC. $14.89 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169905 ABBVIE INC. $17.68 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169907 ABBVIE INC. $17.02 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169909 ABBVIE INC. $4.80 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169911 ABBVIE INC. $15.00 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169913 ABBVIE INC. $18.45 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169915 ABBVIE INC. $17.68 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169917 ABBVIE INC. $24.22 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169919 ABBVIE INC. $11.70 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169921 ABBVIE INC. $9.68 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169923 ABBVIE INC. $11.60 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169925 ABBVIE INC. $10.84 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169927 ABBVIE INC. $17.51 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169929 ABBVIE INC. $17.71 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169931 ABBVIE INC. $15.72 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169933 ABBVIE INC. $12.22 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105169935 ABBVIE INC. $22.14 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145320105 Galderma Laboratories, L.P. $13.77 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145320107 Galderma Laboratories, L.P. $16.67 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145320109 Galderma Laboratories, L.P. $14.92 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145320111 Galderma Laboratories, L.P. $15.17 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147926045 REVANCE THERAPEUTICS, INC. $21.76 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147926047 REVANCE THERAPEUTICS, INC. $21.03 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147926049 REVANCE THERAPEUTICS, INC. $147.06 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147926051 REVANCE THERAPEUTICS, INC. $12.13 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147926053 REVANCE THERAPEUTICS, INC. $35.32 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147926055 REVANCE THERAPEUTICS, INC. $35.38 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147926057 REVANCE THERAPEUTICS, INC. $15.79 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147926059 REVANCE THERAPEUTICS, INC. $22.18 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.